The upregulation of the expression of CDC42 is closely related to the development and metastasis of gastric cancer, breast cancer, and lung cancer (Du et al., 2016; Cruz-Collazo et al., 2021; Yao et al., 2021). Here, CDC42 is linked to breast cancer.